|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C12P 21/08 | |||
| C07K 16/40 |
| (11) | Number of the document | 2608809 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11820759.6 |
| Date of filing the European patent application | 2011-08-26 | |
| (97) | Date of publication of the European application | 2013-07-03 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/049448 |
| Date | 2011-08-26 |
| (87) | Number | WO 2012/027721 |
| Date | 2012-03-01 |
| (30) | Number | Date | Country code |
| 377886 P | 2010-08-27 | US |
| (72) |
MCCAULEY, Scott Alan, US
VAYSBERG, Maria, US
|
| (73) |
Gilead Biologics, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | ANTIBODIES TO MATRIX METALLOPROTEINASE 9 |
| ANTIBODIES TO MATRIX METALLOPROTEINASE 9 |